Clinical trials: Coronary Revascularization
Diabetes Mellitus, Insulin Resistance
Diabetes Genome Project: A Prospective Registry to Identify Genetic Variation Among Diabetic Patients
Previous scientific research has found multiple genes that affect the risk for developing heart disease or complications during the treatment of heart disease.
- Conditions
- Diabetes Mellitus, Insulin Resistance, Atherosclerosis
- Trial name
- DGP (NCT00428961)
- Where
- United States
- Volunteers
- 1,607 people, healthy volunteers welcome
- Sponsor
- Saint Luke's Health System
Coronary Occlusion
Optical Coherence Tomography to Improve Outcome for Coronary Revascularisation Using Bioresorbable Vascular Scaffolds
Fully Bioresorbable Vascular Scaffolds (BVS) have been introduced with the objective to preserve native vessel geometry, allow for adaptive vessel remodeling with late lumen gain, restore physiological vasomotion, and avoid late…
- Trial name
- OPTICO-BVS (NCT02683356)
- Testing
- OCT-guided PCI, Angiography-guided PCI
- Where
- Switzerland
- Volunteers
- 38 people, healthy volunteers welcome
- Sponsor
- Insel Gruppe AG, University Hospital Bern
Coronary Artery Disease
Eliminate Coronary Artery Disease
The purpose of this study is to determine whether pharmacologic lowering of low density lipoprotein cholesterol (LDL), initiated in healthy young to middle aged adults can eliminate or markedly reduce the composite endpoint of…
- Trial name
- ECAD (NCT02245087)
- Testing
- Atorvastatin
- Where
- 3 sites in Canada
- Volunteers
- 28 people, healthy volunteers welcome
- Sponsor
- University Health Network, Toronto
Ischemic Heart Disease
Oral Glutamine in Cardiopulmonary Bypass
Introduction: Glutamine (GLN) is the most abundant free amino acid in the body. It modulates immune cell function and is an important energy substrate for most cells (especially for enterocytes and lymphocytes) in critical…
- Trial name
- NCT02491931
- Volunteers
- 28 people, healthy volunteers welcome
- Sponsor
- Instituto Mexicano del Seguro Social